Search
  1. Home
  2. Africa
  • News

Three AIDS drugs scrapped by WHO

    JOHANNESBURG

    Three generic versions of anti-AIDS drugs produced by India's Ranbaxy Laboratories have been removed from the World Health Organisation's (WHO) list of approved antiretrovirals.

    The UN health agency said in a statement on Wednesday it was not certain that the drugs were biologically the same as the patented versions.

    "This effectively means that the medicines may or may not offer the same therapeutic benefits as the originals on which they are based," the WHO explained.

    Until Ranbaxy can submit evidence of new tests proving its generics are biologically equivalent to the originals, the anti-AIDS drugs will be kept off the WHO's list of approved treatments.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join